Value of multimodality ultrasound combined with MRI for diagnosis of soft tissue tumors

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300077102

Enrollment

Unknown

Registered

2023-10-31

Start date

2023-11-01

Completion date

Unknown

Last updated

2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue tumor

Interventions

Gold Standard:The pathological results should be considered as the gold standard.

Index test:Aixplorer ultrasound system (SuperSonic Imagine, Aixen-Provence, France) with an L12-5 linear array probe. PHILIPS EPIQ7 (WA, USA) ultrasound system with an L10-3 linear array probe. MRI:

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old; (2) Clinically consider soft tissue tumors in the trunk, limbs, head, and neck; (3) Cases with pathological diagnosis of primary soft tissue tumors; (4) Preoperative ultrasound, clinical, pathological, and MRI data are available.

Exclusion criteria

Exclusion criteria: (1) Common cystic lesions such as ganglion, epidermoid cyst, or Baker's cyst; (2) Skin tumors; Metastatic soft tissue tumors; (3) Severe allergies.

Design outcomes

Primary

Measure	Time frame
The size of soft tissue tumors.;Shear wave velocity;CEUS classification of soft tissue tumors;Parameters for CEUS quantitative analysis of soft tissue tumors.;Accuracy ;Positive predicative value;	—

Secondary

Measure	Time frame
Sensitivity ;Specificity ;	—

Countries

CHINA

Contacts

Public ContactGuanghui Xing

The Fourth Medical Center of Chinese People’s Liberation Army General Hospital

xgh304@sina.com+86 183 1015 6200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026